Robeco Institutional Asset Management B.V. Legend Biotech Corp Transaction History

Robeco Institutional Asset Management B.V.

  • $49.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023
SELL
$46.28 - $75.01 $36,422 - $59,032
-787 Reduced 29.26%
1,903 $131,000
Q1 2023

May 03, 2023
SELL
$43.42 - $57.37 $3.38 Million - $4.46 Million
-77,808 Reduced 96.66%
2,690 $129,000
Q4 2022

Feb 06, 2023
BUY
$38.8 - $55.46 $3.12 Million - $4.46 Million
80,498 New
80,498 $4.02 Million
Q3 2020

Oct 29, 2020
SELL
$27.5 - $39.61 $16,995 - $24,478
-618 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$36.1 - $42.56 $22,309 - $26,302
618 New
618 $26,000

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email